Apotex, Slayback Beat Lymphoma Drug Patent Suit In Del.

By Jasmin Jackson (October 26, 2022, 7:27 PM EDT) -- A Delaware federal judge cleared pharmaceutical companies Apotex and Slayback of patent infringement claims lodged by the maker of cancer drug Belrapzo over their new drug applications, ruling that the disputed products don't meet the "ready to use" limitation in the patent....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!